Faculty Opinions recommendation of The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation.

Maurício Simões Abrão, Luiz Fernando de Oliveira Henrique, João Dias
In: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012 · doi:10.3410/f.717598004.793454352 · W4214747802
dataset OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-09 ⓘ

Elocalcitol, a selective vitamin D receptor agonist, was found to reduce endometriosis development in mice by inhibiting peritoneal inflammation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Read the full review for this Faculty Opinions recommended article: The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK